The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 5, Pages 1078
Publisher
MDPI AG
Online
2021-05-18
DOI
10.3390/microorganisms9051078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
- (2020) Naïm Ouldali et al. LANCET INFECTIOUS DISEASES
- Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study
- (2019) Sandra A Asner et al. CLINICAL INFECTIOUS DISEASES
- Making sense of differences in pneumococcal serotype replacement
- (2019) Joseph A Lewnard et al. LANCET INFECTIOUS DISEASES
- Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data
- (2019) Rahel Schneider et al. VACCINE
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
- (2018) Shamez N Ladhani et al. LANCET INFECTIOUS DISEASES
- Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands
- (2018) Marloes Vissers et al. PLoS One
- Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
- (2018) Jo Southern et al. PLoS One
- The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage
- (2018) Pilar Ciruela et al. VACCINE
- Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey
- (2018) Maurane Riesen et al. BMJ Open
- Probiotics and carriage of Streptococcus pneumoniae serotypes in Danish children, a double-blind randomized controlled trial
- (2018) Sine Fjeldhøj et al. Scientific Reports
- Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci
- (2018) Taj Azarian et al. PLoS Pathogens
- The Swiss National Vaccination Coverage Survey, 2005–2007
- (2017) Phung Lang et al. PUBLIC HEALTH REPORTS
- Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children
- (2016) C. Hays et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
- (2016) Ilias Galanis et al. EUROPEAN RESPIRATORY JOURNAL
- Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasiveStreptococcus pneumoniae, Switzerland, 2004 to 2014
- (2016) Christoph Hauser et al. Eurosurveillance
- Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study
- (2016) Grant A Mackenzie et al. LANCET INFECTIOUS DISEASES
- Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011
- (2016) Andreia N. Horácio et al. PLoS One
- Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
- (2016) F Olearo et al. SWISS MEDICAL WEEKLY
- Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden
- (2016) Ann Lindstrand et al. VACCINE
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
- (2015) Matthew R Moore et al. LANCET INFECTIOUS DISEASES
- Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
- (2014) Zitta Barrella Harboe et al. CLINICAL INFECTIOUS DISEASES
- Serotype epidemiology of invasive pneumococcal disease in Swiss adults: A nationwide population-based study
- (2014) Jurka Meichtry et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
- (2013) Lisa A. Jackson et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
- (2013) Lisa A. Jackson et al. VACCINE
- Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995–2011
- (2013) Wallis Rudnick et al. VACCINE
- Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests
- (2010) R. Achermann et al. CLINICAL MICROBIOLOGY AND INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now